Cargando…
Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729327/ https://www.ncbi.nlm.nih.gov/pubmed/33313275 http://dx.doi.org/10.21037/atm-20-3526 |
| _version_ | 1783621432864931840 |
|---|---|
| author | Oh, Hyunwoo Lee, Jeong-Hoon |
| author_facet | Oh, Hyunwoo Lee, Jeong-Hoon |
| author_sort | Oh, Hyunwoo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7729327 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77293272020-12-11 Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis Oh, Hyunwoo Lee, Jeong-Hoon Ann Transl Med Editorial Commentary AME Publishing Company 2020-11 /pmc/articles/PMC7729327/ /pubmed/33313275 http://dx.doi.org/10.21037/atm-20-3526 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Oh, Hyunwoo Lee, Jeong-Hoon Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis |
| title | Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis |
| title_full | Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis |
| title_fullStr | Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis |
| title_full_unstemmed | Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis |
| title_short | Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis |
| title_sort | tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729327/ https://www.ncbi.nlm.nih.gov/pubmed/33313275 http://dx.doi.org/10.21037/atm-20-3526 |
| work_keys_str_mv | AT ohhyunwoo tivozanibinadvancedinoperablehepatocellularcarcinomaconsiderationsforpatientswithlivercirrhosis AT leejeonghoon tivozanibinadvancedinoperablehepatocellularcarcinomaconsiderationsforpatientswithlivercirrhosis |